Eras Protocol In Maxillofacial Fracture Patients: A Randomized Controlled Trial

Enhanced Recovery after Surgery (ERAS) guidelines have been formulated for various surgical disciplines. The study formulated an ERAS pathway for maxillofacial fracture patients and examined the effectiveness of ERAS protocol. A total of 150 patients with facial fracture planned to undergoing elective open reduction and internal fixation surgery were involved and randomly divided into two groups: Group A (the ERAS group: 74 patients) and Group B (the Control group: 76 patients). The ERAS group patients were treated with an ERAS protocol, the control group patients received traditional care. We compared the differences in perioperative outcomes between two groups of patients. Baseline data had non-significant between the two groups. There were significant decreases in pre-operative fasting time, peri-operative hunger feelings, albumin changes, post-operative pain and other adverse reactions in the ERAS group (P<0.05). Patients in the ERAS group scored better overall satisfaction(P<0.05). While there was no statistically significant difference in length of hospital stay and weight changes between the two groups of patients (P>0.05). Our study suggested that the ERAS protocol is safe and effective for maxillofacial fracture patients. The ERAS protocol could be considered in other maxillofacial surgeries.